CMS Transparency Rules: What Manufacturers Must Prepare For

The market access landscape is shifting. This time, the catalyst isn’t just pricing reform. It’s transparency. The Centers for Medicare & Medicaid Services (CMS) is expanding disclosure requirements around pricing, contracting, and value justification. What used...

Preparing for 2026: 5 Priorities for Market Access Leaders

2026 isn’t far off. Are your access priorities ready for the next wave of IRA-driven disruption? Between Inflation Reduction Act (IRA) implementation milestones, global pricing pressures, and payer adoption of new contracting models, the next 18 months will redefine...

From Insight to Action: Why Many Teams Stall at the Last Mile

Gathering insight is one thing. Acting on it fast enough to matter? That’s the real differentiator. Across pharma and biotech, manufacturers invest heavily in market access research—payer interviews, advisory panels, and data dashboards that reveal how coverage...

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Launch plans rarely survive first contact with payers. One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access. Then they tested it with MAVA®. Launch...